Life Science Leader Magazine Supplements

CMO 2016

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/646761

Contents of this Issue

Navigation

Page 57 of 63

K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M 2016 CMO LEADERSHIP AWARDS WINNERS Company Profiles LIFESCIENCELEADER.COM THE CMO LEADERSHIP AWARDS 2016 58 CAPABILITIES COMPATIBILITY EXPERTISE QUALITY RELIABILITY INDIVIDUAL ATTRIBUTE AWARDS: reputation, strength of science INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on-time, reputation, right first time, state-of-the-art, strength of science INDIVIDUAL ATTRIBUTE AWARDS: accessible senior management, cultural fit, innovation, on-time, reputation, right first time, state-of-the-art, strength of science SERVICES & CAPABILITIES: cytotoxic & high potency compounds, peptides, proteins "With these awards, Lonza is being recognized for our quality initiatives, reliability, expertise, and compatibility. In 2015 our efforts resulted in successful regulatory inspections and customer audits at our cGMP sites, supporting our rank as a reliable partner. We strive continuously to reach the next level of excellence in commercial and innovation activities to help our customers' value chains. We are a more customer-focused and market-driven organization and believe our high rankings reflect this change." SERVICES & CAPABILITIES: ADC payloads, chromatography, CMO services, cytotoxic & high potency compounds, generics, hazardous chemistry, mAbs, peptides, proteins, purification, vaccines, viral vectors "Sincere thanks to all the customers and partners who voted for us in these 15 categories. Our commitment and efforts in delivering first-class service to our customers have been recognized. For three years, our new strategy has focused on day-to-day activities to meet the needs of our partners and customers. These awards support our teams in delivering the projects announced this year: a state-of-the-art ADC conjugation facility and the expansion of our U.S. laboratory." SERVICES & CAPABILITIES: aseptic fill/finish, cell culture, cell & virus banking, cytotoxic & high potency compounds, fermentation, formulation, injectables, liquids, non-sterile, parenterals (small volume), peptides, process development, purification, proteins, solutions & suspensions, sterile, vaccines DRUG TYPE: Biopharmaceuticals DRUG TYPE: Pharmaceuticals, Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production DRUG LIFE CYCLE STAGES: Research & Development: Clinical (Phase 1, Phase 2, Phase 3) Drug Substance Production: Primary Process Development, Drug Substance Production DRUG LIFE CYCLE STAGES: Research & Development: Discovery, Preclinical, Clinical (Phase 1) Drug Substance Production: Primary Process Development, Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging DRUG TYPE: Biopharmaceuticals RICHARD RIDINGER CEO THIERRY VAN NIEUWENHOVE President, Synthesis Business Unit CATEGORIES WON CATEGORIES WON CATEGORIES WON Paragon Bioservices, Inc. Baltimore, MD www.paragonbioservices.com +1 410 975 4050 Philip Wills pwills@paragonbioservices.com Key locations: Baltimore, MD NOVASEP Lyon, France www.novasep.com +33 437 282 030 Andrew Brennan andrew.brennan@novasep.com Key locations: Le Mans, France; Mourenx, France; Pompey, France; Leverkusen, Germany; Seneffe, Belgium; Boothwyn, PA, U.S.A. Lonza Basel, Switzerland www.lonza.com +41 61 316 81 11 Sean Diver sean.diver@lonza.com Key locations: Houston, TX, Portsmouth, NH, Walkersville, MD, U.S.A.; Porriño, Spain; Slough, UK PETER BUZY President & CFO "Responsibility to our clients, a passion for science, and our collective need to contribute to better public health — that's what keeps us motivated and excited about the work that we perform. We are driven by our commitment to provide exceptional quality, scientific excellence, and superior customer service. We bring 25 years of experience working with biologics to every client project — from research and process development services to GMP manufacturing for Phase 1-2 clinical trials."

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine Supplements - CMO 2016